Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection

Standard propensity score methods estimate treatment effects in populations defined by overlap between treatment groups, restricting inference to a subpopulation that may not reflect the full clinically relevant population—a critical limitation in COVID-19 observational research.

Target RWE researchers published a methodological analysis demonstrating how IPTW and other propensity score variants differ in the population to which they generalize, using COVID-19 therapeutic observational studies as illustrative examples.

Demonstrating that IPTW enables inference over the full eligible population advances the generalizability of Target RWE's comparative effectiveness analyses, supporting the FDA research collaboration and positioning its analytic approach as a regulatory-grade standard.

IPTW vs. matched propensity score generalizability comparison for regulatory-grade RWE study design, Methodological demonstration of population-level inference for FDA-facing observational studies